WINT
WINDTREE THERAPEUTICS INC /DE/Company Information
- Company Name
- WINDTREE THERAPEUTICS INC /DE/
- CIK
- CIK0000946486
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- WINT: OTC, WINTW: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- WINT
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-10-08
- Last sale
- 2021-12-30
- Shares purchased (TTM)
- 5,431
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-06-30
- Institutional shares owned
- 16,960
- Shares outstanding
- 4,877,257
- Ownership
- 0.35%
Earnings Market Reaction
- Filing date
- 2025-11-19
- Price on filing date
- —
- 1-month reaction
- 12.65%
- 3-month reaction
- -79.59%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 1 | 2 | 2 | 2 | 3 | 4 | 7 | 11 | 4 | 6 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 7 | 7 | 2 | 3 | 4 | 2 | 3 | 5 | 9 | 13 | 5 | 7 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 0 | 0 | 1 | 2 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | ||||||
| Notes And Loans Receivable Net Current | 6 | 5 | - | - | - | - | - | - | - | - | - | - | ||||||
| Deposits Assets Current | - | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | 8 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Goodwill | - | - | - | - | - | - | - | 0 | 0 | 0 | 3 | 3 | ||||||
| Assets | 16 | 32 | 27 | 28 | 30 | 29 | 30 | 32 | 36 | 41 | 35 | 38 | ||||||
| Accounts Payable Current | 2 | 4 | 3 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 0 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 22 | 16 | 6 | 6 | 14 | 9 | 5 | 4 | 4 | 4 | 3 | 2 | ||||||
| Senior Notes Current | - | - | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 3 | 8 | - | - | - | - | - | - | - | - | - | - | ||||||
| Loans Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | - | - | - | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Deferred Income Tax Liabilities Net | 2 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Liabilities | 28 | 25 | 15 | 15 | 24 | 18 | 15 | 29 | 29 | 29 | 28 | 28 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | 0 | 3 | 1 | 3 | 2 | 7 | - | 0 | - | - | - | - | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 881 | 868 | 864 | 860 | 856 | 853 | 853 | 851 | 850 | 850 | 839 | 838 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -12 | 4 | 10 | 10 | 4 | 3 | 15 | 3 | 7 | 12 | 7 | 10 | ||||||
| Treasury Stock Value | - | - | - | - | - | - | - | - | - | - | - | -3 | ||||||
| Retained Earnings Accumulated Deficit | -889 | -861 | -851 | -847 | -849 | -847 | -835 | -845 | -840 | -835 | -829 | -825 | ||||||
| Treasury Stock Common Value | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | ||||||
| Liabilities And Stockholders Equity | 16 | 32 | 27 | 28 | 30 | 29 | 30 | 32 | 36 | 41 | 35 | 38 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | ||||||
| Common Stock Shares Issued | 34 | 9 | 4 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 34 | 9 | 4 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialWINDTREE THERAPEUTICS INC /DE/ (WINT) — SEC Financial Statements & Analysis
WINDTREE THERAPEUTICS INC /DE/ (WINT) is a biological products, (no diagnostic substances) company, incorporated in DE. WINDTREE THERAPEUTICS INC /DE/ trades on OTC as: WINT, WINTW. WINDTREE THERAPEUTICS INC /DE/ (WINT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-19. Based on that filing, WINDTREE THERAPEUTICS INC /DE/ carries a market cap of $1.80M, a P/E ratio of -0.05x, a P/B ratio of -0.15x, an enterprise value of $4.29M, and an EV/EBITDA multiple of -0.13x. On profitability, it posts a Return on Equity (ROE) of 1106.68%, a Return on Assets (ROA) of -171.64%, and a Return on Invested Capital (ROIC) of -287.33%. Per share, it reports EPS of $-1.49, free cash flow per share of $-0.57, and a dividend per share of $0.01. Over the trailing year, it posted net income growth of 272.08% year-over-year and EPS growth of 147.44% year-over-year. On the balance sheet, it maintains a current ratio of 0.33x, a quick ratio of 0.27x, working capital of $-14.70M, a debt-to-equity ratio of -2.38x, a debt ratio of 1.73, an interest coverage ratio of -68.64x, free cash flow of $-15.12M (TTM), and net debt of $2.50M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.80M
- P/E TTM
- -0.05x
- EPS TTM
- $-1.49
- P/B TTM
- -0.15x
- ROE TTM
- 1106.68%
- ROA TTM
- -171.64%
- Debt To Equity
- -2.38x
- Free Cash Flow TTM
- $-15.12M
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is WINDTREE THERAPEUTICS INC /DE/ in?
WINDTREE THERAPEUTICS INC /DE/ (WINT) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does WINT trade on?
WINDTREE THERAPEUTICS INC /DE/ (WINT) trades on the OTC.
Where is WINDTREE THERAPEUTICS INC /DE/ incorporated?
WINDTREE THERAPEUTICS INC /DE/ is incorporated in DE.
When was WINDTREE THERAPEUTICS INC /DE/ (WINT)'s most recent SEC filing?
WINDTREE THERAPEUTICS INC /DE/ (WINT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-19.
What is WINT's market cap?
WINDTREE THERAPEUTICS INC /DE/ (WINT) has a market capitalization of $1.80M as of 2025-09-30.
What is WINT's EPS (earnings per share)?
WINDTREE THERAPEUTICS INC /DE/ (WINT)'s trailing twelve month EPS is $-1.49 as of 2025-09-30.
What is WINT's ROE (return on equity)?
WINDTREE THERAPEUTICS INC /DE/ (WINT)'s trailing twelve month Return on Equity (ROE) is 1106.68% as of 2025-09-30.
What is WINT's ROA (return on assets)?
WINDTREE THERAPEUTICS INC /DE/ (WINT)'s trailing twelve month Return on Assets (ROA) is -171.64% as of 2025-09-30.
What is WINT's ROIC (return on invested capital)?
WINDTREE THERAPEUTICS INC /DE/ (WINT)'s trailing twelve month Return on Invested Capital (ROIC) is -287.33% as of 2025-06-30.
What is WINT's EV/EBITDA?
WINDTREE THERAPEUTICS INC /DE/ (WINT)'s trailing twelve month EV/EBITDA is -0.13x as of 2025-09-30.